US Patent Issued to CIS Biopharma on Jan. 20 for "High hyaluronate multi-purpose disinfection solutions for ophthalmic applications" (Swiss, German Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,327, issued on Jan. 20, was assigned to CIS Biopharma AG (Bubendorf, Switzerland).

"High hyaluronate multi-purpose disinfection solutions for ophthalmic applications" was invented by Christian Geraths (Rheinfelden, Germany) and Rolf Schafer (Arisdorf, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to ophthalmic formulations wherein a synergistic combination of three different classes of disinfectants (a multimeric biguanide compound, a quaternary ammonium compound and an antifungal/anti-acanthamoeba compound, in particular a combination of polyhexamethylene biguanide, Polyquaternium-1 and myristamidopropyl d...